8-KEarnings & ResultsOther EventsExhibits & Filings

METLIFE INC 8-K Report, Financial Results (Jul 31, 2019)

Filed July 31, 2019For Securities:METMET-PEMET-PFMET-PA

Summary

MetLife, Inc. (MET) filed an 8-K on July 31, 2019, primarily to report its financial results for the second quarter ended June 30, 2019. The company released its Earnings Release, a Quarterly Financial Supplement, and Supplemental Slides, providing detailed financial information and operational performance for the period. Investors should refer to these attached exhibits for a comprehensive understanding of the company's financial condition and results of operations. In addition to the quarterly results, the filing also announced a significant capital return initiative. MetLife's Board of Directors approved a new authorization to repurchase up to $2 billion of the company's common stock. This demonstrates management's confidence in the company's financial health and its commitment to enhancing shareholder value through share buybacks.

Key Highlights

  • 1MetLife reported its financial results for the quarter ended June 30, 2019.
  • 2Detailed financial information was provided through an Earnings Release, Quarterly Financial Supplement, and Supplemental Slides.
  • 3The company's Board of Directors approved a new share repurchase program.
  • 4The approved share repurchase program has an authorization of $2 billion.
  • 5The 8-K filing includes exhibits that are furnished, not filed, per SEC instructions.
  • 6This filing indicates proactive capital management and commitment to shareholder returns.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce MetLife's financial results for the second quarter ended June 30, 2019, and to disclose a new $2 billion share repurchase authorization approved by its Board of Directors.

The detailed financial results are available in the exhibits attached to the 8-K filing: Exhibit 99.1 (Earnings Release), Exhibit 99.2 (Quarterly Financial Supplement), and Exhibit 99.3 (Supplemental Slides).

The $2 billion share repurchase authorization signifies management's confidence in MetLife's financial stability and its strategy to return capital to shareholders, which can potentially increase earnings per share and boost shareholder value.

No, according to the filing, these exhibits are furnished and not filed pursuant to instruction B.2 of Form 8-K. This means they are provided for informational purposes but do not carry the same legal liability as formally filed documents.